Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CALCR | P30988 | 3/20 | 0.66 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.65 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.65 |
| ▸ | GLP1R | P43220 | 9/20 | 0.65 |
| ▸ | CCKBR | P32239 | 1/20 | 0.64 |
| ▸ | PTH1R | Q03431 | 2/20 | 0.64 |
| ▸ | VIPR1 | P32241 | 2/20 | 0.63 |
| ▸ | TFPI | P10646 | 1/20 | 0.63 |
| ▸ | VIPR2 | P41587 | 1/20 | 0.61 |
| ▸ | ECE1 | P42892 | 1/20 | 0.61 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29628152 | 0.98 | CALCR (0.66) | CALCRCRHR1CRHR2GLP1RCCKBR | |
| SCHEMBL29836025 | 0.98 | CALCR (0.66) | CALCRCRHR1CRHR2GLP1RCCKBR | |
| SCHEMBL719111 | 0.98 | CALCR (0.66) | CALCRCRHR1CRHR2GLP1RCCKBR | |
| SCHEMBL25303269 | 0.98 | CALCR (0.66) | CALCRCRHR1CRHR2GLP1RCCKBR | |
| SCHEMBL29628018 | 0.98 | CALCR (0.66) | CALCRCRHR1CRHR2GLP1RCCKBR | |
| SCHEMBL15787075 | 0.97 | CALCR (0.64) | CALCRCRHR1CRHR2GLP1RCCKBR | |
| SCHEMBL29750818 | 0.97 | CALCR (0.66) | CALCRCRHR1CRHR2GLP1RCCKBR | |
| SCHEMBL29628084 | 0.96 | CALCR (0.66) | CALCRCRHR1CRHR2GLP1RCCKBR | |
| SCHEMBL29628017 | 0.96 | CALCR (0.66) | CALCRCRHR1CRHR2GLP1RCCKBR | |
| SCHEMBL30529017 | 0.94 | PTH1R (0.65) | CALCRCRHR1CRHR2GLP1RCCKBR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111670196-B | Humanized and deimmunized antibodies | 维沃永治疗公众有限公司 | 2024-10-01 | — | — | CN | disclosed |
| CN-108699139-B | Humanized antibodies | 维沃永治疗公众有限公司 | 2022-06-24 | — | — | CN | disclosed |